Literature DB >> 11531166

Antagonism of morphine-induced antinociception by tetrandrine is dependent on serotonergic mechanisms.

Y H Zhang1, L H Fang.   

Abstract

'Tetrandrine (TET), a non-specific calcium antagonist, inhibited morphine-induced antinociception in the tail-flick test in mice. This study was undertaken to assess the mechanism of the antagonism of morphine-induced antinociception by TET. Morphine-induced antinociception was prevented by pretreatment with TET in the tail-flick but not in the tail-pinch tests carried out in mice and this antagonism was abolished by pretreatment of a serotonin precursor, 5-hydroxytryptophan (5-HTP), but not by the pretreatment of a noradrenaline precursor, L-dihydroxyphenylalanine (L-DOPA), in the tail-flick test. These results indicate that serotonergic mechanisms are involved in the antagonism of morphine-induced antinociception by TET. On the other hand, the development of morphine-induced analgesic tolerance was not prevented by TET. This result, in agreement with other reports, also indicates the possible dissociation of morphine analgesic effect from its tolerance-inducing effect. In addition, TET suppressed the 5-hydroxytryptamine (5-HT)-induced head twtch response. This result provides additional evidence that TET may modulate serotonergic function and the antagonism of morphine-induced antinociception by TET is dependent on serotonergic mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531166     DOI: 10.1016/s0024-3205(01)01230-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  [Foshouningshen decoction improves sleeping via the serotonergic system in a rat model of insomnia].

Authors:  Jie-Cong Huang; Wei Xie; Ning Deng; Wen-Lin Liang; Dong-Rong Hu; Yu Hong; Yang Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

2.  Tetrandrine attenuated cerebral ischemia/reperfusion injury and induced differential proteomic changes in a MCAO mice model using 2-D DIGE.

Authors:  Lin Ruan; Huan-Sen Huang; Wen-Xiang Jin; Hai-Ming Chen; Xiong-Juan Li; Qing-Juan Gong
Journal:  Neurochem Res       Date:  2013-06-19       Impact factor: 3.996

Review 3.  The potential of tetrandrine as a protective agent for ischemic stroke.

Authors:  Yun Chen; Ya-Hui Tsai; Sheng-Hong Tseng
Journal:  Molecules       Date:  2011-09-16       Impact factor: 4.411

4.  Study on the hypnotic effect of rare protopanaxadiol-type and protopanaxatriol-type ginsenosides.

Authors:  Ning Mou; Zhiguang Duan; Pei Ma; Rongzhan Fu; Daidi Fan
Journal:  RSC Adv       Date:  2019-07-01       Impact factor: 3.361

5.  Tetrandrine alleviates cerebral ischemia/reperfusion injury by suppressing NLRP3 inflammasome activation via Sirt-1.

Authors:  Jun Wang; Ming Guo; Ruojia Ma; Maolin Wu; Yamei Zhang
Journal:  PeerJ       Date:  2020-05-07       Impact factor: 2.984

Review 6.  A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji).

Authors:  Yueping Jiang; Min Liu; Haitao Liu; Shao Liu
Journal:  Phytochem Rev       Date:  2020-04-24       Impact factor: 5.374

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.